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Synthesis of enantiomerically pure d-benzylproline
derivatives†
Isabel Rodrı´guez, M. Isabel Calaza, Ana I. Jime´nez and Carlos Cativiela*
The (2S,5R) stereoisomer of 5-benzylproline, i.e. the L-proline analogue that bears a d-benzyl substituent
cis to the carbonyl function, has been prepared in enantiomerically pure form and excellent global yield.
The procedure involves the construction of the pyrrolidine ring through intramolecular cyclization and
uses as starting material the enantiopure b-amino acid obtained by homologation of L-phenylalanine.
The generation of an intermediate vinyl triflate with full regiochemical control followed by a
stereoselective hydrogenation reaction allowed the isolation of the target d-substituted L-proline
analogue in optically pure form and 43% overall yield from the initial b-amino acid. The trans
stereoisomer of (2R,5R) configuration is obtained as a minor product through a less stereoselective
hydrogenation reaction.
Introduction
One of the most eﬃcient approaches to control peptide con-
formation is the incorporation of amino acids with restricted
conformational flexibility into the peptide chain. Among
proteinogenic residues, only proline exhibits clearly defined
conformational propensities.1 This is due to the presence of the
five-membered pyrrolidine ring that includes the a carbon
and the amino function, thus precluding rotation around the
N–Ca bond. As a consequence, proline cannot adopt the fully
extended conformation and acts as a turn inductor in peptide
chains.1,2 Another effect associated to the cyclic nature of
proline is the relative high probability of the so-called prolyl
peptide bond (that formed by the pyrrolidine nitrogen and the
carbonyl group of the preceding residue) to accommodate a cis
arrangement.1,3
The singular structure of proline may serve as a scaﬀold
for the construction of new amino acids with well-defined
conformational tendencies and, indeed, extensive research
has been conducted on the synthesis of proline analogues with
diﬀerent types of modifications.4,5 In particular, the attach-
ment of substituents to the pyrrolidine cycle gives rise to non-
proteinogenic residues that should retain the conformational
propensities of the natural amino acid while incorporating new
side-chain functionalities. Such a combination of structural
and functional properties makes substituted prolines very
helpful to stabilize structural motifs in peptides and is parti-
cularly appealing in the case of proline analogues that bear side
chains belonging to other proteinogenic amino acids. More-
over, by adequately choosing the position, nature, and steric
bulk of the new substituent incorporated, the conformational
propensities of the parent amino acid may be adjusted.5,6
In this regard, attachment of a substituent to the d position
of the pyrrolidine cycle (C-5) aﬀects the cis–trans isomerization
state of the prolyl peptide bond,5,6 which is governed by steric
interactions of the acyl moiety linked to the pyrrolidine nitro-
gen with the contiguous a and d positions of the pyrrolidine
cycle. Thus, proline analogues with considerable steric hind-
rance at Cd such as d,d-dimethylproline and d-tert-butylproline
have been shown to stabilize the cis state of this peptide bond,7
which, in turn, affects the overall conformation of the peptide
backbone. The possibility to modulate amide geometry by using
d-substituted prolines has been applied, for example, to investi-
gate the folding pathways of therapeutic proteins,3a,8 to elucidate
the receptor-bound conformation of bioactive peptides,7c,d,9 or
to establish the role of amide cis–trans isomerization of a
single proline residue in switching the open/closed states of
a neurotransmitter-gated ion channel.10 Moreover, several
proline analogues containing aromatic substituents at the d
position have been used in the design of peptide-based
pharmacologically active compounds.11 Among these analogues
is d-benzylproline,11d,e which combines the conformational
constraints of proline with the side chain of phenylalanine. This
proline–phenylalanine hybrid amino acid may not only provide
fundamental insights into the precise conformational require-
ments for optimal receptor binding affinity in bioactive peptides,
but can also be very useful to understand the influence of
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aromatic interactions in peptide folding and prolyl amide
isomerization.
The exploitation of d-benzylproline requires ready access to
the diﬀerent stereoisomers of this amino acid in optically pure
form. The most general methods for the synthesis of enantio-
pure or highly enantioenriched d-substituted prolines make use
of substrates with a pre-formed proline skeleton in which the
desired substituent at Cd is further installed4d,e,5 (Scheme 1,
routes a, b). In particular, L-pyroglutamic acid derivatives have
been used as precursors for the synthesis of two d-benzylproline
stereoisomers.12 Alternatively, the five-membered pyrrolidine
ring can be formed by intramolecular cyclization of adequately
functionalized acyclic precursors.5 Among the cyclization strate-
gies giving rise to highly enantioenriched or enantiomerically
pure d-substituted prolines, the approach described by Davis,13
which involves the use of chiral sulfinimines (496% ee) derived
from aldehydes (Scheme 1, route c), is the most eﬃcient and
versatile one. However, the synthesis of enantiopure d-benzyl-
proline by this method seems unfeasible because it would
require the use of a sulfinimine that undergoes facile isomeriza-
tion to the tautomeric enamine,14 thereby compromising pre-
servation of optical purity. A few reports specifically oriented to
the synthesis of d-benzylproline through stereoselective cycliza-
tion reactions have been described and entail the laborious
preparation and transformation of a chiral oxaziridine15a or
acetylene-containing amino acid.15b Herein, we present a
practical procedure for the synthesis of an enantiopure
d-benzylproline stereoisomer that makes use of a homochiral
b-amino acid as the starting material. This methodology can be
viewed as complementary to Davis’ approach13 since it is
amenable to extension to other readily available enantiopure
b-amino acids, thus giving access to d-substituted prolines that
are not accessible by Davis’ procedure.
Results and discussion
We have recently shown that b-amino acids are suitable pre-
cursors for the synthesis of racemic proline analogues substi-
tuted at the b and/or d positions of the pyrrolidine ring.16 Thus,
we carried out the preparation of racemic b-phenylproline16a by
cyclization of an a-diazo-b-ketoester derived from b-alanine
through an intramolecular N–H insertion reaction mediated
by a metal carbenoid17,18 and further functionalization of the
intermediate b-ketoproline formed to incorporate the aromatic
substituent. We subsequently showed that the procedure is applic-
able to the b-alanine derivative possessing two geminal methyl
groups at C-3, which enabled the synthesis of d,d-dimethyl-b-
phenylproline and d,d-dimethylproline.16b In both cases, non-
chiral b-amino acids were used as substrates and the substituted
proline analogues were obtained in racemic form.16 Yet the
procedure should be adequate for the preparation of enantio-
merically pure prolines with different substitution patterns
by using homochiral b-amino acids as starting materials. In
particular, we envisioned that the enantiopure b-amino acids
readily accessible from proteinogenic L-amino acids through
well-known racemization-free homologation procedures19 (many
of them are also commercially available) could allow the synthesis
of optically pure d-substituted prolines that incorporate the side
chain of the coded amino acid at the d position (Scheme 2).
The validity of this hypothesis was checked by addressing the
preparation of enantiomerically pure d-benzylproline starting
from the b-amino acid derived from L-phenylalanine. To the best
of our knowledge, no b-amino acid of this type has been used to
date for the synthesis of d-substituted proline derivatives.
The synthetic route began with the preparation of the
desired b-amino acid bearing a tert-butoxycarbonyl (Boc) group
at the amino function as this type of protection is widely used
in standard peptide synthesis and is compatible with the
synthetic transformations to be carried out. This compound,
Boc-L-b-homophenylalanine or (S)-3-(N-tert-butoxycarbonyl)amino-
4-phenylbutanoic acid, is available from commercial sources
albeit at a very high price. Alternatively, it can also be obtained
in multigram quantities and optically pure form by Arndt–Eistert
homologation of non-expensive Boc-L-phenylalanine following
the well-established literature procedure.20 We applied a slightly
modified version of this method. Thus, the mixed anhydride
generated by reaction of Boc-L-phenylalanine with ethyl chloro-
formate20 was treated with trimethylsilyldiazomethane (Scheme 3)
instead of the very hazardous diazomethane20 to form the
Scheme 1 Most general strategies used for the synthesis of enantiopure
or highly enantioenriched d-substituted prolines.
Scheme 2 Proposed access to enantiopure d-substituted prolines from
b-amino acids derived from proteinogenic amino acids.
Scheme 3 Synthesis of the b-amino acid 2. Reagents and conditions:
(a) (i) EtOCOCl, Et3N, THF, 15 to 5 1C; (ii). Me3SiCHN2, MeCN, 4 1C;
(b) Na2CO3, PhCO2Ag, dioxane/water, sonication, rt.
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diazoketone 1. This replacement proved satisfactory even if it
was discarded in the reported procedure.20 Our assay was
based on the described use of trimethylsilyldiazomethane as
a convenient substitute for diazomethane in the Arndt–Eistert
homologation of acyl chlorides21 and its successful applica-
tion to a carboxylic acid activated as a mixed anhydride in a
more complex molecule.22 The conditions described in the
latter work22 proved adequate in our case, when applied to
Boc-L-phenylalanine, and the corresponding diazoketone (1)
was obtained in good yield using the stable and less hazardous
trimethylsilyldiazomethane (Scheme 3). Next, the diazoketone
underwent a rearrangement process20 promoted by silver
benzoate under sonication conditions22,23 to provide the desired
N-Boc-protected b-amino acid (2) in enantiomerically pure form
with retention of configuration.19,24
Construction of the b-ketoproline skeleton was then addressed
(Scheme 4). To this end, we followed the experimental procedure
applied by Sorensen to b-alanine18 with slight variations.16
Thus, the carboxylic acid in 2 was activated with N,N0-carbonyl-
diimidazole and the imidazolide formed reacted with a malonate-
derived soft enolate to aﬀord the b-ketoester 3 after spontaneous
decarboxylation. The crude compound was subjected to a diazo-
transfer reaction by treatment with 4-(acetamido)benzenesulfonyl
azide25 in the presence of triethylamine. The resulting a-diazo-b-
ketoester (4) underwent decomposition promoted by rhodium
diacetate catalysis under heating conditions. The intramolecular
N–H insertion reaction of the metal carbenoid generated in situ
delivered the d-benzyl-b-ketoproline derivative 5 as an inseparable
mixture of cis/trans stereoisomers.26 This mixture was obtained in
72% overall yield from the starting b-amino acid (2) with a single
purification being necessary.
The final step in the route to the target amino acid involved
reduction of the ketone function at the b position (C-3) in 5.
In our previous syntheses of substituted proline analogues
starting from b-amino acids,16 we carried out this transforma-
tion through an intermediate vinyl triflate (triflate: trifluoro-
methanesulfonate, OTf). By using the adequate combination of
base and triflating agent, we have established the conditions
for the formation of this intermediate triflate in a completely
regioselective manner so that only the regioisomer with a
double bond connecting the a and b carbons (C-2, C-3) is
obtained.16 Accordingly, there are two reasons to prefer the
formation of this intermediate vinyl triflate over other methodo-
logies for the reduction of the carbonyl moiety at C-3 in
compound 5. First, as the intramolecular cyclization reaction
giving rise to 5 (Scheme 4) proceeds with low diastereo-
selectivity,26 hydrogenation of the double bond in this triflate
provides a further opportunity to obtain the desired d-benzyl-
proline with a higher degree of stereocontrol at the a carbon.
Second, if desired, the triflate moiety at the b carbon may
serve for the incorporation of additional substituents at this
position, as demonstrated in our previous work.16
Therefore, we undertook the generation of the vinyl triflate 6
(Scheme 5) by applying the combination of base and triflating agent
that proved essential to achieve full regiocontrol when dealing
with other 3-ketoproline derivatives previously investigated.16 Thus,
deprotonation of 5 (mixture of cis/trans diastereoisomers) with
potassium bis(trimethylsilyl)amide (KHMDS) gave an enolate
that was trapped with N-(5-chloro-2-pyridyl)triflimide (Comins’
reagent27) to yield 6 as a single regioisomer.28 Compound 6
proved stable enough for chromatographic purification and
when stored at 20 1C.
With the aim to obtain the desired d-benzylproline, triflate 6
was first subjected to a palladium-catalyzed reductive removal
Scheme 4 Synthesis of the d-benzyl-b-ketoproline 5 from the b-amino
acid 2. Reagents and conditions: (a) N,N0-carbonyldiimidazole, MgCl2,
THF, rt; (b) 4-(acetamido)benzenesulfonyl azide, Et3N, MeCN, rt;
(c) Rh2(OAc)4, toluene, 85–90 1C.
Scheme 5 Synthesis of enantiomerically pure d-benzylprolinates 8 and 9.
Reagents and conditions: (a) KHMDS, N-(5-chloro-2-pyridyl)triflimide,
THF, rt; (b) Et3SiH, Pd(PPh3)4, LiCl, Et3N, DMF, 75 1C; (c) H2, Pd/C, MeOH,
rt; (d) TFA, CH2Cl2, rt; (e) separation of diastereoisomers by column
chromatography; (f) Boc2O, CH2Cl2, rt; (g) H2, Pd/C, Na2CO3, MeOH, rt.
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of the triflate moiety using triethylsilane as the hydride source
(Scheme 5). The resulting a,b-dehydroproline derivative (7) was
then submitted to hydrogenation to generate the saturated five-
membered ring. Treatment of 7 with hydrogen gas at atmo-
spheric pressure in the presence of palladium on carbon as a
catalyst proceeded with quantitative yield but only moderate
diastereoselectivity, so that a 73 : 27 mixture of d-benzyl-
prolinates 8 was formed (Scheme 5), as deduced from the
1H-NMR spectrum. The 8 diastereoisomers could not be
separated by column chromatography and, therefore, their
cis/trans relative configuration [corresponding, respectively, to
a (2S,5R)/(2R,5R) absolute stereochemistry29] was not established
at this stage. Yet a cis relative disposition of substituents around
the pyrrolidine ring, and hence a (2S,5R) absolute configuration,
was tentatively assigned to the major diastereoisomer assuming
that hydrogenation had preferentially taken place on the less
hindered face of the molecule, that is, opposite the benzyl
substituent. Luckily enough, chromatographic separation of
diastereoisomers was possible after removal of the Boc group
of the (2RS,5R)-8 mixture under standard acidic conditions
(Scheme 5). For characterization purposes, samples of the pure
amino esters thus isolated, (2S,5R)-9 and (2R,5R)-9, were trans-
formed into the corresponding N-Boc-protected precursors,
(2S,5R)-8 and (2R,5R)-8, respectively (Scheme 5). In this way,
the (2S,5R) and (2R,5R) stereoisomers of 8 and 9 were obtained in
optically pure form.29
The stereochemistry of the enantiomerically pure 8 and 9
d-benzylprolinates obtained (Scheme 5) was first established by
2D NOESY experiments performed on the amino esters. A nOe
correlation was observed between the a and d protons only for
the major 9 stereoisomer, indicating a cis relative disposition of
the benzyl and carboxylate substituents in this compound, that
is, a (2S,5R) absolute configuration. This result is in agreement
with the stereoselectivity expected for the hydrogenation
process. The stereochemical assignment was corroborated by
X-ray diﬀraction analysis of single crystals of the N-acetyl
derivative obtained by reaction of the minor amino ester with
acetic anhydride (Fig. 1). The R configuration at C-5, given by
the starting b-amino acid derived from L-phenylalanine, was
taken as a reference in these assignments.
In the search for a more selective, and hence eﬃcient,
procedure for the synthesis of (2S,5R)-d-benzylproline, com-
pound 6 was treated directly with hydrogen gas at atmospheric
pressure using palladium on carbon as a catalyst. Under these
conditions, removal of the triflate group and reduction of the
olefin moiety occurred to cleanly aﬀord a mixture of d-benzyl-
prolinates 8 (Scheme 5). The combined yield of (2S,5R)-/(2R,5R)-
8 isolated was substantially higher (97% vs. 67% when obtained
through the intermediate D2-pyrroline 7) but, unfortunately,
the same 73 : 27 ratio of cis/trans diastereoisomers was deter-
mined in the 1H-NMR spectrum of the crude product.30 There-
fore, the direct 6 to 8 transformation allowed the isolation of
the major d-benzylprolinate (2S,5R)-9 [as well as the minor
(2R,5R)-9 stereoisomer] with significantly improved yield and
avoiding one synthetic step. Accordingly, the synthesis of the
intermediate 7 had no advantage in the route to the target
d-benzylprolinates 8/9. Even so, it should be noted that
compound 7 is an enantiomerically pure a,b-dehydroproline
derivative that may be useful as such for diﬀerent types of
studies. Moreover, 7 is also an interesting intermediate for the
preparation of d-benzylprolinates with further functionaliza-
tion at the b (and a) position(s) taking advantage of the
reactivity of the endocyclic conjugated double bond. The same
holds true for 6, whose triflate moiety could enable the incor-
poration of additional substituents at the b carbon by means of
cross-coupling reactions.16
In a further attempt to increase the diastereoselectivity of
the process, the catalytic hydrogenation of triflate 6 was explored
under diﬀerent conditions. When palladium on carbon was
replaced by platinum oxide, the cis 8 diastereoisomer, (2S,5R)-
8, was formed with higher diastereoselectivity, with only a small
amount of the trans stereoisomer being detected in the 1H-NMR
spectrum of the crude product.31 In this way, after removal of the
Boc group, the pure cis amino ester, (2S,5R)-9, was obtained in
85% yield from 6 (Scheme 6). This modification therefore
allowed the synthesis of enantiomerically pure d-benzylprolinate
(2S,5R)-9 in 43% overall yield from the initial b-amino acid (2).
This d-benzylproline derivative is ready for functionalization at
the amino terminus while the corresponding N-Boc-protected
amino acid suitable for standard peptide synthesis could be
easily obtained following the procedure used for other proline
analogues.32
The results described above show that the b-amino acid
derived from L-phenylalanine allows the eﬃcient synthesis of
the L-proline analogue (S configuration at Ca or C-2) that bears
a d-benzyl substituent cis to the carboxylate moiety [(2S,5R)-8/9
in Schemes 5 and 6]. In principle, this procedure should be
extensible to b-amino acids derived from other proteinogenic
amino acids (available from commercial sources or by well-
known stereocontrolled homologation procedures19) thus
providing access to enantiomerically pure cis d-substituted
L-proline analogues that contain the side chain of such coded
Fig. 1 X-ray crystal structure of the acetyl derivative (2R,5R)-10 obtained
from the minor amino ester, (2R,5R)-9. Hydrogen atoms have been
omitted for clarity.
Scheme 6 Optimized synthesis of (2S,5R)-9 from 6. Reagents and
conditions: (a) H2, PtO2, Na2CO3, MeOH, rt; (b) TFA, CH2Cl2, rt.
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amino acids at the d position (note that the diastereoselectivity
of the hydrogenation reaction may depend, to a great extent, on
the nature of the substituent at Cd and therefore diﬀer from
that observed in this work for the L-phenylalanine derivative).
The present methodology therefore complements that devel-
oped by Davis,13 which has proven successful for the preparation
of enantiopure d-substituted prolines of the same configuration
(cis d-substituted L-prolines) with other types of substituents,
namely aryl, vinyl, or tert-butyl (in general, those derived from
aldehydes with no hydrogen at the a position or possessing a
non-enolizable a hydrogen) but would not be adequate when the
substituent at Cd is the side chain of a proteinogenic amino acid.
In all such cases the aldehyde to be used as the starting material
has an enolizable a hydrogen and the chiral sulfinimine formed
would be susceptible to the imine–enamine equilibrium leading
to epimerization at the stereogenic centre14 that corresponds
to C-5 in the final d-substituted proline, thus hampering the
isolation of enantiopure compounds.
Conclusions
A convenient procedure has been developed for the preparation
of an enantiomerically pure L-proline analogue characterized by
a d-benzyl substituent cis to the carboxylate moiety. The frag-
ment of the pyrrolidine ring bearing the benzyl group derives
from L-phenylalanine. Thus, the synthetic route starts with the
b-amino acid obtained by homologation of L-phenylalanine
and involves the construction of a 3-oxopyrrolidine through
an intramolecular cyclization reaction. The formation of an
intermediate vinyl triflate with complete regioselectivity and
the good diastereoselectivity attained in the subsequent hydro-
genation of this compound using platinum oxide as a catalyst
have allowed the isolation of the final cis d-substituted L-proline
derivative, methyl (2S,5R)-5-benzylprolinate, in enantiomeri-
cally pure form and 43% overall yield. If desired, the corre-
sponding trans stereoisomer, methyl (2R,5R)-5-benzylprolinate,
can be isolated as a minor product through a less diastereo-
selective palladium-catalyzed hydrogenation reaction. Clearly,
starting from D-phenylalanine, the (2R,5S) and (2S,5S) stereo-
isomers would be obtained as major and minor products,
respectively. The procedure could be adequate for extension
to b-amino acids derived from proteinogenic residues other
than L-phenylalanine, thus allowing the synthesis of enantio-
merically pure d-substituted proline analogues bearing the
side chain of diﬀerent coded amino acids at the d carbon.
This methodology complements other previously described
methods for the synthesis of enantiopure or highly enantio-
enriched d-substituted prolines.
Experimental
Single-crystal X-ray diﬀraction
Colourless single crystals of (2R,5R)-10 were obtained by slow
evaporation of a solution in dichloromethane–hexanes. The
X-ray diffraction data were collected at 295 K on an Oxford
Diffraction Xcalibur diffractometer provided with a Sapphire
CCD detector, using graphite monochromated Mo-Ka radiation
(l = 0.71073 Å). The structure was solved by direct methods
using SHELXS-9733a and refinement was performed using
SHELXL-9733b by the full-matrix least-squares technique with
anisotropic thermal factors for heavy atoms. Hydrogen atoms
were located by calculation and affected by an isotropic thermal
factor fixed to 1.2 times the Ueq of the carrier atom (1.5 for the
methyl protons). CCDC 1024381. Summary of crystallographic
data for (2R,5R)-10 (C15H19NO3): monoclinic, space group P21;
a = 9.7435(8) Å, b = 6.5523(4) Å, c = 11.9590(12) Å,
b = 105.802(10)1; Z = 2; dcalcd = 1.181 g cm
3; 2659 reflections
collected, 2297 unique (Rint = 0.020); data/parameters: 2297/
175; final R indices (I 4 2s(I)): R1 = 0.059, wR2 = 0.128; final R
indices (all data): R1 = 0.085, wR2 = 0.147; goodness of fit: 1.025;
highest residual electron density: 0.12 e Å3.
Syntheses
General. All reagents were used as received from commercial
suppliers without further purification. Thin-layer chromato-
graphy (TLC) was performed on Macherey–Nagel Polygrams
SIL G/UV254 precoated silica gel polyester plates. The products
were visualized by exposure to UV light, iodine vapour, sub-
mersion in ninhydrin stain or in ethanolic solution of phos-
phomolybdic acid. Column chromatography was performed
using 60 M (0.04–0.063 mm) silica gel from Macherey–Nagel.
Melting points were determined on a Gallenkamp apparatus. IR
spectra were registered on a Nicolet Avatar 360 FTIR spectro-
photometer; nmax is given for the main absorption bands.
1H
and 13C NMR spectra were recorded on a Bruker ARX-300,
AV-400 or AV-500 instrument at room temperature, unless
otherwise indicated, and using the residual solvent signal as
the internal standard; chemical shifts (d) are expressed in
parts per million and coupling constants ( J) in hertz. Optical
rotations were measured at room temperature using a JASCO
P-1020 polarimeter. High-resolution mass spectra were obtained
on a Bruker Microtof-Q spectrometer.
(S)-1-Diazo-3-(N-tert-butoxycarbonyl)amino-4-phenylbutan-2-
one, 1. To a stirred solution of N-Boc-L-phenylalanine (2.50 g,
9.42 mmol) in anhydrous tetrahydrofuran (60 mL) at 15 1C,
triethylamine (1.57 mL, 11.30 mmol) and ethyl chloroformate
(1.08 mL, 11.30 mmol) were sequentially added. The mixture
was stirred at 5 1C for 30 min. The precipitated triethylammo-
nium chloride was filtered oﬀ, the solvent was evaporated and
the residue obtained was dissolved in acetonitrile (30 mL). The
solution was cooled to 4 1C and a 2 M solution of (trimethylsilyl)-
diazomethane in diethyl ether (9.42 mL, 18.84 mmol) was added
slowly using a syringe. The reaction mixture was stirred at the
same temperature for 24 h. After that, diethyl ether was added
(20 mL) and the mixture was washed with 10% aqueous citric
acid (3  50 mL), saturated aqueous NaHCO3 (2  50 mL), and
brine (2  50 mL). The organic layer was dried over anhydrous
MgSO4, filtered and evaporated to dryness. The residue was
purified by column chromatography (eluent: ethyl acetate/
hexanes 2 : 3) to give diazoketone 1 as a slightly yellow solid
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(2.37 g, 8.19 mmol, 87% yield). Spectroscopic data were identical
to those reported.20
(S)-3-(N-tert-Butoxycarbonyl)amino-4-phenylbutanoic acid, 2.
To a solution of diazoketone 1 (2.10 g, 7.26 mmol) in dioxane/
water (3 : 1 v/v, 100 mL), sodium carbonate (769 mg, 7.26 mmol)
and silver benzoate (42 mg, 0.18 mmol) were added. The resulting
suspension was sonicated for 45 min in an ultrasound bath.
The silver salts were filtered oﬀ and the reaction mixture was
diluted with water and washed with diethyl ether (2 60 mL). The
aqueous phase was acidified to pH 2 with 1 M HCl and extracted
with ethyl acetate (3  80 mL). The combined organic layers were
dried over anhydrous MgSO4, filtered and evaporated under
reduced pressure. The resulting residue was purified by column
chromatography (eluent: hexanes/ethyl acetate 4 : 1 containing
1% acetic acid) to aﬀord 2 as a white solid (1.75 g, 6.26 mmol,
86% yield). [a]21D  16.3 (c 1.84 in MeOH); lit.20 [a]20D  15.7 (c 1.84
in MeOH) for 99% ee. Spectroscopic data were identical to those
reported.20
Methyl (2RS,5S)-N-(tert-butoxycarbonyl)-5-benzyl-3-oxopyrro-
lidine-2-carboxylate, 5. A solution of 2 (1.50 g, 5.37 mmol) in
anhydrous tetrahydrofuran (30 mL) kept at room temperature
under an argon atmosphere was treated with N,N0-carbonyl-
diimidazole (1.00 g, 6.44 mmol). After stirring for 1 h, previously
mixed magnesium chloride (511 mg, 5.37 mmol) and methyl
monopotassium malonate (1.26 g, 8.06 mmol) were added.
The resulting mixture was stirred at room temperature for an
additional 18 h. The solvent was evaporated and the residue was
dissolved in ethyl acetate (25 mL) and washed with 5% aqueous
KHSO4 (3 25mL), 5% aqueous NaHCO3 (3 25mL), and brine
(3  25 mL). The organic layer was dried over MgSO4, filtered
and evaporated under reduced pressure to aﬀord a solid (1.43 g)
that was used in the next step without further purification.
The crude compound was dissolved in anhydrous acetonitrile
(20 mL), under an argon atmosphere, and 4-(acetamido)benzene-
sulfonyl azide (1.13 g, 4.69 mmol) was added in one portion,
followed by triethylamine (1.80 mL, 12.78 mmol). The resulting
mixture was stirred at room temperature for 2 h. The solvent was
concentrated in vacuo and the residue was dissolved in diethyl
ether (25 mL) and washed with saturated aqueous NaHCO3
(3  25 mL), saturated aqueous NH4Cl (3  25 mL) and brine.
The organic layer was dried over anhydrous MgSO4, filtered and
evaporated under reduced pressure to aﬀord a solid (1.40 g)
that was taken on without purification. A solution of the crude
solid in anhydrous toluene (55 mL) kept under an argon
atmosphere was treated with Rh2(OAc)4 (8 mg, 0.019 mmol).
The reaction mixture was heated at 85–90 1C for approximately
40 min in a preheated oil bath. The solvent was evaporated to
dryness and the residue was purified by column chromato-
graphy (eluent: hexanes/ethyl acetate 2 : 1) to afford 5 as a 2.2 : 1
mixture of diastereoisomers26 (sticky oil, 1.29 g, 3.87 mmol,
72% overall yield). 1H NMR (400 MHz, DMSO-d6, 373 K) (only
signals of the major diastereoisomer are listed): d 1.40 (9H, s),
2.33 (1H, m), 2.65 (1H, m), 2.94 (1H, m), 3.25 (1H, m), 3.74 (3H,
s), 4.43 (1H, m), 4.70 (1H, s), 7.00–7.42 (5H, m). 13C NMR
(100 MHz, DMSO-d6, 373 K) (only signals of the major diastereo-
isomer are listed): d 27.4, 40.6, 41.6, 51.9, 55.0, 65.3, 79.7, 125.8,
127.9, 128.6, 137.5, 152.5, 166.6, 203.5. HRMS (ESI) C18H23NNaO5
[M + Na]+: calcd 356.1529, found 356.1510.
Methyl (S)-N-(tert-butoxycarbonyl)-5-benzyl-3-trifluoromethane-
sulfonyloxy-D2-pyrroline-2-carboxylate, 6. A 0.5 M solution of
KHMDS in toluene (6.60 mL, 3.30 mmol) was added with a syringe
to a solution of 5 (1.00 g, 3.00 mmol) in anhydrous tetrahydrofuran
(34 mL) at room temperature. After stirring for 1 h, N-(5-chloro-2-
pyridyl)triflimide (1.41 g, 3.60 mmol) was added and the resulting
solution was stirred for an additional 4 h. The solvent was
evaporated to dryness and the residue was purified by column
chromatography (eluent: hexanes/ethyl acetate 5 : 1) to aﬀord
pure 6 as an oil (991 mg, 2.13 mmol, 71% yield). [a]21D + 42.9
(c 0.97 in CHCl3). IR (neat) nmax 1749, 1715, 1430, 1394, 1369
cm1. 1H NMR (400 MHz, CDCl3): d 1.37 (9H, s), 2.41 (1H, dd,
J = 17.1 Hz, J = 2.5 Hz), 2.71 (1H, dd, J = 13.4 Hz, J = 9.2 Hz),
3.03 (1H, dd, J = 17.1 Hz, J = 9.6 Hz), 3.09 (1H, dd, J = 13.4 Hz,
J = 4.9 Hz), 3.80 (3H, s), 4.45 (1H, m), 7.12–7.30 (5H, m). 13C
NMR (100 MHz, CDCl3): d 28.1, 33.8, 40.8, 52.7, 59.8, 82.6, 118.4
(q, J = 320.8 Hz), 127.0, 127.1, 128.8, 129.8, 136.1, 138.0, 152.6,
159.6. HRMS (ESI) C19H22F3NNaO7S [M + Na]
+: calcd 488.0961,
found 488.1043.
Methyl (R)-N-(tert-butoxycarbonyl)-5-benzyl-D2-pyrroline-2-
carboxylate, 7. Triethylsilane (300 mL, 1.88 mmol) and triethyl-
amine (520 mL, 3.73 mmol) were added dropwise to a solution
of 6 (430 mg, 0.92 mmol), lithium chloride (117 mg, 2.76 mmol)
and tetrakis(triphenylphosphine)palladium (14 mg, 0.012 mmol)
in anhydrous DMF (16 mL). The reaction mixture was stirred at
75 1C for 50 min, and then the solvent was removed under
reduced pressure. The residue was purified by column chromato-
graphy (eluent: hexanes/ethyl acetate 4 : 1) to aﬀord 7 as an oil
(196 mg, 0.62 mmol, 67% yield). [a]23D + 20.5 (c 0.39 in CHCl3). IR
(neat) nmax 1742, 1704, 1629 cm1. 1H NMR (300 MHz, CDCl3):
d 1.34 (9H, s), 2.13 (1H, ddd, J = 17.9 Hz, J = 3.6 Hz, J = 2.3 Hz),
2.51–2.72 (2H, m), 2.99 (1H, dd, J = 13.2 Hz, J = 5.1 Hz), 3.71
(3H, s), 4.44 (1H, m), 5.62 (1H, m), 7.04–7.28 (5H, m). 13C NMR
(75 MHz, CDCl3): d 28.1, 33.4, 40.8, 51.9, 61.4, 80.9, 118.8, 126.4,
128.3, 129.7, 135.7, 137.3, 152.8, 162.6. HRMS (ESI) C18H23NNaO4
[M + Na]+: calcd 340.1519, found 340.1528.
Methyl (2S,5R)- and (2R,5R)-5-benzylpyrrolidine-2-carboxylates,
(2S,5R)-9 and (2R,5R)-9
From 7. A solution of 7 (300 mg, 0.95 mmol) in methanol
(30 mL) was stirred at room temperature under hydrogen gas at
atmospheric pressure in the presence of 10% Pd/C (30 mg).
After 16 h, the catalyst was filtered oﬀ and washed with
methanol. The solvent was concentrated in vacuo to furnish a
73 : 27 mixture of (2S,5R)-8/(2R,5R)-8 (302 mg, 0.95 mmol, 100%
yield). The crude oil was dissolved in dichloromethane (6 mL)
and trifluoroacetic acid (3 mL) was added. After stirring at
room temperature for 2 h, the mixture was washed with
saturated aqueous NaHCO3 (3  5 mL) and brine (2  5 mL).
The organic layer was dried over MgSO4, filtered and evapo-
rated under reduced pressure. The residue was purified
by column chromatography (eluent: ethyl acetate/dichloro-
methane 7 : 3) to aﬀord 110 mg of (2S,5R)-9, 32 mg of (2R,5R)-
9, and 55 mg of (2S,5R)-9/(2R,5R)-9 mixture (0.90 mmol, 95%
combined yield).
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From 6. A mixture of 6 (330 mg, 0.71 mmol), sodium
carbonate (23 mg, 0.21 mmol) and 10% Pd/C (33.0 mg) in
methanol (20 mL) was stirred for 1 h at room temperature
under hydrogen gas at atmospheric pressure. The catalyst
was filtered oﬀ and washed with methanol. The solvent was
concentrated in vacuo to furnish a 73 : 27 mixture of (2S,5R)-8/
(2R,5R)-8 (220 mg, 0.69 mmol, 97% yield) that was treated as
described above.
(2S,5R)-9. Oil. [a]27D  33.5 (c 0.50 in MeOH). IR (neat) nmax
3350, 1736 cm1. 1H NMR (500 MHz, CDCl3): d 1.43 (1H, m),
1.84 (1H, m), 1.95 (1H, m), 2.09 (1H, m), 2.23 (1H, br s), 2.75
(1H, dd, J = 13.4 Hz, J = 6.9 Hz), 2.88 (1H, dd, J = 13.4 Hz,
J = 6.9 Hz), 3.33 (1H, m), 3.70 (3H, s), 3.77 (dd, J = 8.9 Hz, J =
5.9 Hz), 7.14–7.29 (5H, m). 13C NMR (75 MHz, CDCl3): d 29.9,
31.2, 42.3, 52.2, 59.8, 61.3, 126.3, 128.5, 129.0, 139.8, 175.7.
HRMS (ESI) C13H18NO2 [M + H]
+: calcd 220.1332, found
220.1334.
(2R,5R)-9. Oil. [a]27D + 11.8 (c 0.29 in MeOH). IR (neat) nmax
3349, 1737 cm1. 1H NMR (500 MHz, CDCl3): d 1.48 (1H, m),
1.86 (2H, m), 2.24 (1H, m), 2.31 (1H, br s), 2.66–2.80 (2H, m),
3.49 (1H, m), 3.69 (3H, s), 3.88 (1H, dd, J = 8.7 Hz, J = 5.3 Hz),
7.15–7.24 (3H, m), 7.25–7.32 (2H, m). 13C NMR (75 MHz,
CDCl3): d 29.4, 31.2, 42.9, 52.1, 59.2, 59.9, 126.2, 128.5, 129.1,
139.9, 176.4. HRMS (ESI) C13H17NNaO2 [M + Na]
+: calcd
242.1151, found 242.1150.
Methyl (2S,5R)-5-benzylpyrrolidine-2-carboxylate, (2S,5R)-9.
A mixture of 6 (100 mg, 0.22 mmol), sodium carbonate (12 mg,
0.11 mmol) and PtO2 (1.50 mg) in methanol (2 mL) was stirred
for 1 h at room temperature under hydrogen gas at atmospheric
pressure. The catalyst was filtered oﬀ and washed with methanol.
The solvent was concentrated in vacuo. The residue was dissolved
in dichloromethane (3 mL) and washed with water. The organic
layer was dried over MgSO4, filtered and evaporated under
reduced pressure. The residue was dissolved in dichloromethane
(3 mL) and trifluoroacetic acid (1.5 mL) was added. After stirring
at room temperature for 2 h, the mixture was washed with
saturated aqueous NaHCO3 (3  5 mL) and brine (2  5 mL).
The organic layer was dried over MgSO4, filtered and evaporated
under reduced pressure. The residue was purified by column
chromatography (eluent: ethyl acetate/dichloromethane 7 : 3) to
aﬀord (2S,5R)-9 (40 mg, 0.18 mmol, 85% yield). Spectroscopic
data were identical to those described above.
Methyl (2S,5R)-N-(tert-butoxycarbonyl)-5-benzylpyrrolidine-
2-carboxylate, (2S,5R)-8. A solution of (2S,5R)-9 (50mg, 0.23mmol)
in dichloromethane (5 mL) was treated with di-tert-butyl dicarbo-
nate (75 mg, 0.34 mmol). After stirring at room temperature for
1 h, the mixture was washed with water (2  5 mL) and brine
(5 mL). The organic layer was dried over MgSO4, filtered and
evaporated under reduced pressure. The residue was purified
by column chromatography (eluent: hexanes/ethyl acetate 3 : 1)
to aﬀord pure (2S,5R)-8 as an oil (70 mg, 0.22 mmol, 96% yield).
[a]24D  55.9 (c 0.32 in CHCl3). IR (neat) nmax 1752, 1697 cm1.
1H NMR (400 MHz, CDCl3) (mixture of rotamers, asterisks
indicate signals corresponding to the minor rotamer): d 1.36
and 1.39* (9H, two br s), 1.57–1.83 (2H, m), 1.95 (1H, m), 2.13
(1H, m), 2.51 (1H, m), 3.20* and 3.34 (1H, two dd, J = 13.3 Hz, J =
4.6 Hz, and J = 13.3 Hz, J = 4.0 Hz, respectively), 3.69 and 3.70*
(3H, two s), 3.96* and 4.05 (1H, two m), 4.17 and 4.29* (1H, two
m), 7.06–7.29 (5H, m). 13C NMR (100 MHz, CDCl3) (duplicate
signals are observed for almost all carbon atoms): d 28.2/28.3,
28.46/28.5, 28.9/29.6, 39.8/41.0, 52.1/52.3, 60.0, 60.3, 60.4,
80.16/80.18, 126.2/126.3, 128.5/128.6, 129.5/129.6, 139.3/139.4,
153.7/154.4, 174.0/174.1. HRMS (ESI) C18H25NNaO4 [M + Na]
+:
calcd 342.1676, found 342.1648.
Methyl (2R,5R)-N-(tert-butoxycarbonyl)-5-benzylpyrrolidine-
2-carboxylate, (2R,5R)-8. A solution of (2R,5R)-9 (65 mg,
0.30 mmol) in dichloromethane (7 mL) was treated with
di-tert-butyl dicarbonate (97 mg, 0.45 mmol). After stirring at
room temperature for 1 h, the mixture was washed with water
(2  5 mL) and brine (5 mL). The organic layer was dried
over MgSO4, filtered and evaporated under reduced pressure.
The residue was purified by column chromatography (eluent:
hexanes/ethyl acetate 3 : 1) to aﬀord (2R,5R)-8 as an oil (89 mg,
0.28 mmol, 94% yield). [a]24D + 54.1 (c 0.36 in CHCl3). IR (neat)
nmax 1747, 1697 cm
1. 1H NMR (400 MHz, CDCl3) (mixture of
rotamers, asterisks indicate signals corresponding to the minor
rotamer): d 1.37 and 1.47* (9H, two s), 1.62 (1H, m), 1.73 (1H,
m), 1.78–1.98 (2H, m), 2.50* and 2.55 (1H, two overlapped dd,
J = 13.1 Hz, J = 9.5 Hz, and J = 13.3 Hz, J = 9.5 Hz, respectively,
1H), 2.98* and 3.06 (1H, two dd, J = 13.2 Hz, J = 3.3 Hz, and
J = 13.1 Hz, J = 3.3 Hz, respectively), 3.62 and 3.63* (3H, two s),
4.01–4.16 (1H, m), 4.17–4.34 (1H, m), 7.04–7.28 (5H, m). 13C
NMR (100 MHz, CDCl3) (duplicate signals are observed for
almost all carbon atoms, asterisks indicate signals corre-
sponding to the minor rotamer): d 26.8/27.4*, 27.6*/28.3,
28.5/28.6*, 39.6/40.5*, 52.0/52.2*, 59.5, 59.7, 60.1, 80.1/80.3*,
126.4/126.5*, 128.5/128.6*, 129.5*/129.7, 138.9*/139.0, 153.8/
154.4*, 173.4*/173.8. HRMS (ESI) C18H25NNaO4 [M + Na]
+: calcd
342.1676, found 342.1671.
Methyl (2R,5R)-N-acetyl-5-benzylpyrrolidine-2-carboxylate,
(2R,5R)-10. A solution of (2R,5R)-9 (31 mg, 0.14 mmol) in
chloroform (2 mL) was treated with sodium acetate (35 mg,
0.42 mmol) and acetic anhydride (40 mL, 0.42 mmol). After
stirring at room temperature for 4 h, the mixture was washed
with saturated aqueous NaHCO3 (2  5 mL) and brine
(2  5 mL). The organic layer was dried over MgSO4, filtered
and evaporated under reduced pressure. The residue was
purified by column chromatography (eluent: hexanes/ethyl
acetate 1 : 4) to aﬀord (2R,5R)-10 as a white solid (26 mg,
0.10 mmol, 69% yield). mp 89–90 1C. [a]23D + 23.3 (c 0.18 in
CHCl3). IR (nujol) nmax 1747, 1635 cm1. 1H NMR (400 MHz,
CDCl3) (mixture of rotamers, asterisks indicate signals corre-
sponding to the minor rotamer): d 1.66–2.23 (4H, m) over-
lapped with 1.99* and 2.14 (3H, two s), 2.55–2.76 (1H, m), 2.93
and 3.20* (1H, two dd, J = 13.7 Hz, J = 4.3 Hz and J = 13.2 Hz,
J = 3.1 Hz, respectively), 3.71 and 3.74* (3H, two s), 4.17 and
4.41* (1H, two m), 4.26* and 4.38 (1H, two m), 7.11–7.37 (5H, m).
13C NMR (100 MHz, CDCl3) (duplicate signals are observed for all
carbon atoms, asterisks indicate signals corresponding to the
minor rotamer): d 22.1/23.0*, 26.5*/26.9, 28.5/29.3*, 38.6*/41.2,
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52.2/52.7*, 59.2/61.1*, 59.6*/60.5, 126.4*/127.0, 128.5*/128.9,
129.3/129.6*, 137.7/139.1*, 169.77/169.8*, 172.86*/172.9. HRMS
(ESI) C15H19NNaO3 [M + Na]
+: calcd 284.1257, found 284.1249.
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